RRC Q1 2026 Earnings Strong EPS Beat Highlights Operational Efficiency EPM Q1 2026 Earnings Deep EPS Miss Punishes Stock as Revenue Details Remain Unreported Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management ICCM Q1 2026 Earnings EPS Misses Estimates as Losses Widen GTES Q1 2026 Earnings EPS Beat Driven by Operational Efficiency and Demand PETS Q1 2026 Earnings Significant Earnings Miss Despite Positive Stock Reaction